# Wnt/β-catenin signalling modulates the timing of cell fate decision making in the early mouse embryo

**Authors:** Joaquin Lilao-Garzón, Elena Corujo-Simon, Meritxell Vinyoles, Sabine C. Fischer, José Guillén, Tina Balayo, Silvia Muñoz-Descalzo, Gregory Kelly, Gregory Kelly, Gregory Kelly

PMC · DOI: 10.1371/journal.pone.0344295 · 2026-03-06

## TL;DR

This study shows that the Wnt/β-catenin signaling pathway influences when cells in early mouse embryos decide their fate, helping them become primitive endoderm cells.

## Contribution

The study reveals a dual role of Wnt/β-catenin signaling in modulating cell fate decisions in mouse embryos, beyond the known FGF/ERK pathway.

## Key findings

- Wnt/β-catenin signaling promotes primitive endoderm differentiation when active.
- Inhibition of Wnt/β-catenin signaling delays cell fate decisions in early embryos.
- The pathway stabilizes GATA6 and GATA4, aiding in primitive endoderm cell fate.

## Abstract

Cell fate choice is a key event happening during preimplantation mouse development. From embryonic day 3.5 (E3.5) to E4.5, the inner cell mass (ICM) differentiates into epiblast (Epi, NANOG expressing cells) and primitive endoderm (PrE, GATA6, SOX17 and/or GATA4 expressing cells). The mechanism by which ICM cells differentiate into Epi cells and PrE cells remains partially unknown. FGF/ERK has been proposed as the main signalling pathway for this event, but it does not explain co-expression of NANOG and GATA6 or how the cell fate choice is initiated. In this study, we investigate whether Wnt/β-catenin signalling also plays a role. To this end, we use two in vitro models based on inducible GATA6 expression: one in 2D (flat cultured cells), and another in 3D, namely ICM organoids. By combining these in vitro models with in vivo mouse embryos, chemical and classical genetics, and quantitative 3D immunofluorescence analyses, we propose a dual role for Wnt/β-catenin signalling. We find that β-catenin, acting alongside FGF/ERK signalling, helps to guide the cell fate choice towards PrE. Additionally, by regulating GATA6 and GATA4 stability, Wnt/β-catenin signalling further facilitates this choice. To summarise, we observe that Wnt/β-catenin signalling pathway activation promotes PrE differentiation, while its inhibition delays it.

## Linked entities

- **Genes:** NANOG (Nanog homeobox) [NCBI Gene 79923], GATA6 (GATA binding protein 6) [NCBI Gene 2627], SOX17 (SRY-box transcription factor 17) [NCBI Gene 64321], GATA4 (GATA binding protein 4) [NCBI Gene 2626]
- **Proteins:** ctnnb1.S (catenin beta 1 S homeolog)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Pou5f1 (POU domain, class 5, transcription factor 1) [NCBI Gene 18999] {aka NF-A3, Oct-3, Oct-3/4, Oct-4, Oct3, Oct3/4}, Fgf2 (fibroblast growth factor 2) [NCBI Gene 14173] {aka Fgf-2, Fgf2a, Fgfb, bFGF}, Fgf4 (fibroblast growth factor 4) [NCBI Gene 14175] {aka Fgf-4, Fgf7a, Fgfk, HBGF-4, Hst1, Hstf-1}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Fn1 (fibronectin 1) [NCBI Gene 14268] {aka E330027I09, Fn, Fn-1}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, Sox17 (SRY (sex determining region Y)-box 17) [NCBI Gene 20671], GATA6 (GATA binding protein 6) [NCBI Gene 2627], Gsk3a (glycogen synthase kinase 3 alpha) [NCBI Gene 606496] {aka 2700086H06Rik}, CTNNB1 (catenin beta 1) [NCBI Gene 477032], Aqp8 (aquaporin 8) [NCBI Gene 11833] {aka AQP-8}, Wnt3a (wingless-type MMTV integration site family, member 3A) [NCBI Gene 22416] {aka Wnt-3a, vt}, NANOG [NCBI Gene 486701], SOX7 (SRY-box transcription factor 7) [NCBI Gene 83595], Dkk1 (dickkopf WNT signaling pathway inhibitor 1) [NCBI Gene 13380] {aka mdkk-1}, GATA6 (GATA binding protein 6) [NCBI Gene 490520], Fgfr1 (fibroblast growth factor receptor 1) [NCBI Gene 14182] {aka Eask, FGFR-I, FLG, Fgfr-1, Flt-2, Fr1}, Sparc (secreted acidic cysteine rich glycoprotein) [NCBI Gene 20692] {aka BM-40, ON}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, Lef1 (lymphoid enhancer binding factor 1) [NCBI Gene 16842] {aka 3000002B05, Lef-1}, Gata6 (GATA binding protein 6) [NCBI Gene 14465] {aka GATA-6}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Zp3 (zona pellucida glycoprotein 3) [NCBI Gene 22788] {aka Zp-3}, Gata4 (GATA binding protein 4) [NCBI Gene 14463] {aka Gata-4}, GATA4 (GATA binding protein 4) [NCBI Gene 2626] {aka ASD2, TACHD, TOF, VSD1}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], SOX17 (SRY-box transcription factor 17) [NCBI Gene 64321] {aka PPH7, VUR3}, Dusp4 (dual specificity phosphatase 4) [NCBI Gene 319520] {aka 2700078F24Rik, E130306H24Rik, MKP2}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, NANOG (Nanog homeobox) [NCBI Gene 79923], Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Nanog (Nanog homeobox) [NCBI Gene 71950] {aka 2410002E02Rik, ENK, Stm1, ecat4}, Sox2 (SRY (sex determining region Y)-box 2) [NCBI Gene 20674] {aka Sox-2, lcc, ysb}
- **Diseases:** ICM (MESH:C536030), PrE (MESH:D018240), obesity (MESH:D009765), neck dislocation (MESH:D006258), toxicity (MESH:D064420)
- **Chemicals:** sc- (MESH:D012538), CHIR99021 (MESH:C473711), polyacrylamide (MESH:C016679), N (MESH:D009584), dox (MESH:D004318), DAPI (MESH:C007293), PBS (MESH:D007854), Cycloheximide (MESH:D003513), AZD4547 (MESH:C572463), CO2 (MESH:D002245), XAV939 (MESH:C544261), Dox (MESH:D004317), puromycin (MESH:D011691), -WN-002 (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** S10A
- **Cell lines:** PrE — Bos taurus (Bovine), Spontaneously immortalized cell line (CVCL_L860), N-S17 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_B2H2), sc-419477 — Homo sapiens (Human), Follicular lymphoma, Cancer cell line (CVCL_1888), mESCs — Homo sapiens (Human), Embryonic stem cell (CVCL_UI95), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), N — Homo sapiens (Human), Finite cell line (CVCL_UZ57), N-G4 — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_XP06)

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965605/full.md

---
Source: https://tomesphere.com/paper/PMC12965605